Showing results (1581-1590 of 1,722) with videos related to

Sort By:
Pageof 173
Neuro-Oncology|August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaThomas J Kaley, Patrick Wen, David Schiff, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Stroke|September 13, 2019
Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression ProfileBabak B Navi, Ryna Mathias, Carla P Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, John Kuhn, H Ian Robins, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 29, 2016
Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22Rachel McDonald, Keyue Ding, Edward Chow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
Journal of Clinical Medicine|November 11, 2020
Systemic Disease and Ocular Comorbidity Analysis of Geographically Isolated Federally Recognized American Indian Tribes of the Intermountain WestPatrice M Hicks, Benjamin Haaland, Michael Feehan, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 4, 2016
Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapySrinivas Raman, Keyue Ding, Edward Chow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 9, 2024
2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patientsSamantha K F Kennedy, Shannon Goodall, Shing Fung Lee, et al.
Pageof 173